Report Detail
Global Nuclear Medicine Radioisotopes Market Growth 2019-2024
- RnM3216156 |
- 30 March, 2019 |
- Global |
- 159 Pages |
- LPI(LP Information) |
- Other
Nuclear medicine has a huge potential in treating cancer and cardiac diseases. Growth of medical imaging is an opportunity for the growth of the global nuclear medicine radioisotope market, as both markets are correlated. Radiopharmaceuticals are approved by the Food and Drug Administration (FDA) as either drugs or biologics.
According to this study, over the next five years the Nuclear Medicine Radioisotopes market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Nuclear Medicine Radioisotopes business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Medicine Radioisotopes market by product type, application, key manufacturers and key regions and countries.
This study considers the Nuclear Medicine Radioisotopes value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Thallium-201 (Tl-201)
Iodine (I-123)
Fluorine-18
Rubidium-82 (Rb-82)
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
Tumor
Heart Disease
Lymphoma
Thyroid Gland
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Agfa-Gevaert Group
Braco
Cardiarc
Cardinal Health
CMR Naviscan (Gamma Medica Inc.)
Curium
Digirad
GE Healthcare
Nordion (Canada)
NTP Radioisotopes SOC
Positron
Segami
Siemens Healthcare
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Nuclear Medicine Radioisotopes consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Nuclear Medicine Radioisotopes market by identifying its various subsegments.
Focuses on the key global Nuclear Medicine Radioisotopes manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Nuclear Medicine Radioisotopes with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Nuclear Medicine Radioisotopes submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Nuclear Medicine Radioisotopes Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Nuclear Medicine Radioisotopes Consumption 2014-2024
- 2.1.2 Nuclear Medicine Radioisotopes Consumption CAGR by Region
- 2.2 Nuclear Medicine Radioisotopes Segment by Type
- 2.2.1 Thallium-201 (Tl-201)
- 2.2.2 Iodine (I-123)
- 2.2.3 Fluorine-18
- 2.2.4 Rubidium-82 (Rb-82)
- 2.2.5 Other
- 2.3 Nuclear Medicine Radioisotopes Consumption by Type
- 2.3.1 Global Nuclear Medicine Radioisotopes Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Nuclear Medicine Radioisotopes Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Nuclear Medicine Radioisotopes Sale Price by Type (2014-2019)
- 2.4 Nuclear Medicine Radioisotopes Segment by Application
- 2.4.1 Tumor
- 2.4.2 Heart Disease
- 2.4.3 Lymphoma
- 2.4.4 Thyroid Gland
- 2.4.5 Other
- 2.5 Nuclear Medicine Radioisotopes Consumption by Application
- 2.5.1 Global Nuclear Medicine Radioisotopes Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Nuclear Medicine Radioisotopes Value and Market Share by Application (2014-2019)
- 2.5.3 Global Nuclear Medicine Radioisotopes Sale Price by Application (2014-2019)
3 Global Nuclear Medicine Radioisotopes by Players
- 3.1 Global Nuclear Medicine Radioisotopes Sales Market Share by Players
- 3.1.1 Global Nuclear Medicine Radioisotopes Sales by Players (2017-2019)
- 3.1.2 Global Nuclear Medicine Radioisotopes Sales Market Share by Players (2017-2019)
- 3.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Players
- 3.2.1 Global Nuclear Medicine Radioisotopes Revenue by Players (2017-2019)
- 3.2.2 Global Nuclear Medicine Radioisotopes Revenue Market Share by Players (2017-2019)
- 3.3 Global Nuclear Medicine Radioisotopes Sale Price by Players
- 3.4 Global Nuclear Medicine Radioisotopes Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Nuclear Medicine Radioisotopes Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Nuclear Medicine Radioisotopes Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Nuclear Medicine Radioisotopes by Regions
- 4.1 Nuclear Medicine Radioisotopes by Regions
- 4.1.1 Global Nuclear Medicine Radioisotopes Consumption by Regions
- 4.1.2 Global Nuclear Medicine Radioisotopes Value by Regions
- 4.2 Americas Nuclear Medicine Radioisotopes Consumption Growth
- 4.3 APAC Nuclear Medicine Radioisotopes Consumption Growth
- 4.4 Europe Nuclear Medicine Radioisotopes Consumption Growth
- 4.5 Middle East & Africa Nuclear Medicine Radioisotopes Consumption Growth
5 Americas
- 5.1 Americas Nuclear Medicine Radioisotopes Consumption by Countries
- 5.1.1 Americas Nuclear Medicine Radioisotopes Consumption by Countries (2014-2019)
- 5.1.2 Americas Nuclear Medicine Radioisotopes Value by Countries (2014-2019)
- 5.2 Americas Nuclear Medicine Radioisotopes Consumption by Type
- 5.3 Americas Nuclear Medicine Radioisotopes Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Nuclear Medicine Radioisotopes Consumption by Countries
- 6.1.1 APAC Nuclear Medicine Radioisotopes Consumption by Countries (2014-2019)
- 6.1.2 APAC Nuclear Medicine Radioisotopes Value by Countries (2014-2019)
- 6.2 APAC Nuclear Medicine Radioisotopes Consumption by Type
- 6.3 APAC Nuclear Medicine Radioisotopes Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Nuclear Medicine Radioisotopes by Countries
- 7.1.1 Europe Nuclear Medicine Radioisotopes Consumption by Countries (2014-2019)
- 7.1.2 Europe Nuclear Medicine Radioisotopes Value by Countries (2014-2019)
- 7.2 Europe Nuclear Medicine Radioisotopes Consumption by Type
- 7.3 Europe Nuclear Medicine Radioisotopes Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Nuclear Medicine Radioisotopes by Countries
- 8.1.1 Middle East & Africa Nuclear Medicine Radioisotopes Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Nuclear Medicine Radioisotopes Value by Countries (2014-2019)
- 8.2 Middle East & Africa Nuclear Medicine Radioisotopes Consumption by Type
- 8.3 Middle East & Africa Nuclear Medicine Radioisotopes Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Nuclear Medicine Radioisotopes Distributors
- 10.3 Nuclear Medicine Radioisotopes Customer
11 Global Nuclear Medicine Radioisotopes Market Forecast
- 11.1 Global Nuclear Medicine Radioisotopes Consumption Forecast (2019-2024)
- 11.2 Global Nuclear Medicine Radioisotopes Forecast by Regions
- 11.2.1 Global Nuclear Medicine Radioisotopes Forecast by Regions (2019-2024)
- 11.2.2 Global Nuclear Medicine Radioisotopes Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Nuclear Medicine Radioisotopes Forecast by Type
- 11.8 Global Nuclear Medicine Radioisotopes Forecast by Application
12 Key Players Analysis
- 12.1 Agfa-Gevaert Group
- 12.1.1 Company Details
- 12.1.2 Nuclear Medicine Radioisotopes Product Offered
- 12.1.3 Agfa-Gevaert Group Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Agfa-Gevaert Group News
- 12.2 Braco
- 12.2.1 Company Details
- 12.2.2 Nuclear Medicine Radioisotopes Product Offered
- 12.2.3 Braco Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Braco News
- 12.3 Cardiarc
- 12.3.1 Company Details
- 12.3.2 Nuclear Medicine Radioisotopes Product Offered
- 12.3.3 Cardiarc Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Cardiarc News
- 12.4 Cardinal Health
- 12.4.1 Company Details
- 12.4.2 Nuclear Medicine Radioisotopes Product Offered
- 12.4.3 Cardinal Health Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Cardinal Health News
- 12.5 CMR Naviscan (Gamma Medica Inc.)
- 12.5.1 Company Details
- 12.5.2 Nuclear Medicine Radioisotopes Product Offered
- 12.5.3 CMR Naviscan (Gamma Medica Inc.) Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 CMR Naviscan (Gamma Medica Inc.) News
- 12.6 Curium
- 12.6.1 Company Details
- 12.6.2 Nuclear Medicine Radioisotopes Product Offered
- 12.6.3 Curium Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 Curium News
- 12.7 Digirad
- 12.7.1 Company Details
- 12.7.2 Nuclear Medicine Radioisotopes Product Offered
- 12.7.3 Digirad Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Digirad News
- 12.8 GE Healthcare
- 12.8.1 Company Details
- 12.8.2 Nuclear Medicine Radioisotopes Product Offered
- 12.8.3 GE Healthcare Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 GE Healthcare News
- 12.9 Nordion (Canada)
- 12.9.1 Company Details
- 12.9.2 Nuclear Medicine Radioisotopes Product Offered
- 12.9.3 Nordion (Canada) Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 Nordion (Canada) News
- 12.10 NTP Radioisotopes SOC
- 12.10.1 Company Details
- 12.10.2 Nuclear Medicine Radioisotopes Product Offered
- 12.10.3 NTP Radioisotopes SOC Nuclear Medicine Radioisotopes Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 NTP Radioisotopes SOC News
- 12.11 Positron
- 12.12 Segami
- 12.13 Siemens Healthcare
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Nuclear Medicine Radioisotopes . Industry analysis & Market Report on Nuclear Medicine Radioisotopes is a syndicated market report, published as Global Nuclear Medicine Radioisotopes Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Nuclear Medicine Radioisotopes market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
